CellType
ActiveThe agentic drug company. We simulate human biology.
This company has previously operated under “Contextual Bio”. A rename frequently marks a pivot in positioning or product — useful raw material for variant ideas.
About
CellType is building an agentic drug company. AI agents that run the full drug discovery pipeline on top of biological foundation models that simulate human biology. Our core technology, developed with Google DeepMind, has already discovered and validated a new cancer treatment signal. We’re working with Top 10 pharma.
Founders · 2
Co-Founder & CEO of CellType (W26). Yale Professor, 11,000+ citations. Built biological foundation models with Google. Building the agentic drug company.
Co-Founder @ CellType (W26). ML @ Yale & EPFL. Building the next-generation agentic drug company. Co-developed our core technology Cell2Sentence at Yale and published at ICML. Previously led large-scale foundation model training at a biotech startup and built software to control CERN's Large Hadron Collider.
Related startups
AI and Data for Cancer Therapeutics
The AI-native platform for next-generation protein characterization.
